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Abstract  Shiga  toxin-producing  Escherichia  coli  (STEC)  strains  have  emerged  as  important
foodborne  pathogens  of  global  public  health  concern,  causing  life-threatening  diseases.  Sheep
and their  products  have  been  documented  as  important  reservoirs  for  STECs,  especially  E.  coli
O157. The  aim  of  this  study  was  to  investigate  STECs  from  diarrheal  human  and  sheep  in
Al-Madinah  Al-Munawarah,  Saudi  Arabia.  Fecal  samples  were  collected  between  June  and
August, 2015  from  diarrheal  humans  (n  =  134)  and  sheep  (n  =  87).  Presumptive  E.  coli  human-
and sheep-isolated  strains  were  identiﬁed  for  their  serotypes,  the  associated  virulence  genes
(Shiga toxin  [stx1,  stx2],  haemolysin  [ehxA]  and  intimin  [eae])  by  polymerase  chain  reaction  and
their susceptibility  to  antibiotics.  Pulsed-ﬁeld  gel  electrophoresis  (PFGE)  was  used  to  demon-
strate the  genetic  relatedness  between  Serotype  O157:H7  human-  and  sheep-isolated  strains.
Forty eight  (48/221;  21.7%)  STECs  were  recovered  from  both  human  and  sheep,  their  serotypes
were as  follows:  O157:H7,  O26:H11,  O157:HNM,  O26:HNM,  O128:H2,  O48:HNM,  O111:HNM  and
OUT:HUT. Various  virulence  proﬁles  and  multiple  antibiotic  resistance  were  observed  among
the isolates.  Twenty  eight  O157:H7  serotypes  (17  human  isolates  and  11  sheep  isolates)  were
identiﬁed in  13  PFGE  pulsotypes,  where  human  and  sheep  isolates  were  highly  related.  PFGE
banding proﬁles  together  with  serotypes  and  genotypes  afford  proof  that  human  and  sheep  can
be colonized  and  infected  with  similar  E.  coli  O157:H7  strains.  Our  ﬁndings  highlight  the  impor-
tance of  epidemiological  and  microbiological  surveillance  of  STECs;  as  well  as  the  development
of control  measures  to  decrease  risks  associated  with  zoonotic  O157:H7.
© 2016  ACIN.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an  open  access  article  under  the  CC
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Prevalencia  y  caracterización  molecular  de  cepas  de  Escherichia  coli  productoras
de  toxina  Shiga  en  seres  humanos  y  ovejas  de  Al-Medina  Al-Munawarah
Resumen  Las  cepas  de  Escherichia  coli  (E.  coli) productoras  de  toxina  Shiga  (STEC,  del  inglés
Shiga toxin-producing  E.  coli)  han  surgido  como  importantes  agentes  patógenos  de  origen  ali-
mentario que  son  motivo  de  preocupación  para  la  salud  pública  mundial,  ya  que  provocan
enfermedades  potencialmente  mortales.  Se  ha  conﬁrmado  que  las  ovejas  y  sus  productos  son
reservorios  importantes  para  la  STEC,  especialmente  E.  coli  O157.  El  objetivo  de  este  estu-
dio fue  investigar  STEC  procedentes  de  deposiciones  diarreicas  humanas  y  ovinas  en  Al-Medina
Al-Munawarah  (Arabia  Saudí).  Se  recogieron  muestras  fecales  entre  junio  y  agosto  de  2015  de
deposiciones  diarreicas  humanas  (n  =  134)  y  ovinas  (n  =  87).  Se  identiﬁcaron  las  presuntas  cepas
de E.  coli  humanas  y  ovinas  por  sus  serotipos,  los  genes  de  virulencia  asociados  (toxina  Shiga
[stx1, stx2],  hemolisina  [ehxA]  e  intimina  [eae])  por  reacción  en  cadena  de  la  polimerasa  y  la
susceptibilidad  a  los  antibióticos.  Se  utilizó  la  electroforesis  en  gel  de  campo  pulsado  (EGCP)
para demostrar  el  parentesco  genético  entre  el  serotipo  O157:H7  de  las  cepas  humanas  y  el
de las  ovinas.  Se  aislaron  48  STEC  (48/221;  21,7%)  tanto  humanas  como  ovinas  y  sus  serotipos
fueron los  siguientes:  O157:H7,  O26:H11,  O157:HNM,  O26:HNM,  O128:H2,  O48:HNM,  O111:HNM
y OUT:HUT.  Entre  las  cepas  se  observaron  varios  perﬁles  de  virulencia  y  resistencia  a  múltiples
antibióticos  entre  los  aislamientos.  Se  identiﬁcaron  28  serotipos  O157:H7  (17  cepas  humanas  y
11 cepas  ovinas)  en  13  pulsotipos  de  la  EGCP,  en  los  que  las  cepas  humanas  y  ovinas  estaban
sumamente  vinculadas.  Los  perﬁles  de  bandeos  de  la  EGCP,  junto  con  los  serotipos  y  genotipos,
ofrecen una  prueba  de  que  seres  humanos  y  ovejas  pueden  ser  colonizados  e  infectados  por
cepas similares  de  E.  coli  O157:H7.  Nuestros  resultados  destacan  la  importancia  de  la  vigilancia
epidemiológica  y  microbiológica  de  STEC,  así  como  del  desarrollo  de  medidas  de  control  para
reducir los  riesgos  asociados  con  la  O157:H7  zoonótica.
© 2016  ACIN.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un  art´ıculo  Open  Access  bajo  la
licencia CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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higa  toxin-producing  Escherichia  coli  (STEC)  or  verocyto-
oxin  (VT)-producing  E.  coli  (VTEC)  strains  are  pathogens  of
ublic  health  concern  worldwide,  and  associated  with  dis-
ase  in  humans  and  animals.  In  humans,  they  can  cause
evere  outbreaks  of  gastrointestinal  illness  with  clinical
ymptoms  ranging  from  diarrhea  and  hemorrhagic  colitis
o  the  life-threatening  haemolytic  uremic  syndrome.1 STEC
trains  causing  human  infections  belong  to  a  large  number
f  O:H  serotypes.  Most  outbreaks  and  sporadic  cases  of  hem-
rrhagic  colitis  and  haemolytic  uremic  syndrome  (HUS)  have
een  attributed  to  the  STEC  O157  strains;  the  H7  ﬂagel-
um  is  frequently  but  not  always  present  on  O157  isolates.2
owever,  as  STEC  non-O157  strains  are  more  prevalent  in
nimals  and  as  contaminants  in  foods,  humans  are  prob-
bly  more  exposed  to  these  strains.  Infections  with  some
on-O157  STEC  types,  such  as  O26:H11  or  H-,  O91:H21
r  H-,  O103:H2,  O111:H-,  O113:H21,  O117:H7,O118:H16,
121:H19,  O128:H2  or  H-,  O145:H28  or  H-  and  O146:H21  are
requently  associated  with  severe  illness  in  humans,  but  the
ole  of  other  non-O157  STEC  types  in  human  disease  needs
urther  examination.3
STEC  strains  isolated  from  a  variety  of  animals  and
attle  are  considered  the  main  reservoir.4 Nevertheless,Please  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
ecent  studies  have  indicated  that  small  domestic  rumi-
ants,  including  sheep  and  goats,  are  also  key  reservoirs
f  STEC.5,6 In  particular,  sheep  and  their  products  have
een  documented  as  reservoirs  for  STECs  that  belong  to  a
t
r
siverse  set  of  non-O157  serogroups  (O26,  O91,  O115,O128,
nd  O130)  and  possess  genes  encoding  key  virulence  factors
hat  have  been  implicated  in  human  disease.7 Human  infec-
ions  commonly  derived  from  beef  products,  un-pasteurized
ilk  and  contaminated  water,  during  the  processing  of  the
arcasses,  fecal  contamination  and/or  transfer  of  bacteria
rom  the  animal’s  hide  to  the  carcass  can  facilitate  trans-
ission  of  pathogenic  E.  coli  to  the  meat.8
Gulf  states,  especially  Saudi  Arabia  is  a  major  sheep
mporter  of  meat.  It  represents  the  world’s  largest  import
arket  for  live  sheep  to  meet  the  strong  consumer  demand,
s  sheep  meat  forms  an  important  component  of  the  Arab
iet.9
Shiga  toxin-producing  E.  coli  are  characterized  by  the
roduction  of  one  or  more  types  of  Shiga  toxin  (stx1 or  stx2
r  their  variants),  which  interfere  with  the  protein  synthe-
is  of  host  cells,  leading  to  cell  death.  These  toxins  are
ynonymously  either  called  verocytotoxins  because  of  their
ctivity  on  Vero  cells  or  Shiga  toxins  because  of  their  sim-
larity  with  the  toxin  produced  by  Shigella  dysenteriae. In
ddition  to  toxin  production,  another  virulence-associated
actor  expressed  by  STEC  is  a  protein  called  intimin,  which
s  responsible  for  intimate  attachment  of  STEC  to  intesti-
al  epithelial  cells,  causing  attaching  and  effacing  lesions
n  the  intestinal  mucosa.  Intimin  is  encoded  by  the  chro-
osomal  gene  eae, which  is  part  of  a  pathogenicity  islandI.  Prevalence  and  molecular  characterization  of  Shiga
 sheep  in  Al-Madinah  Al-Munawarah.  Infectio.  2016.
ermed  the  locus  for  enterocyte  effacement.  Severe  diar-
hea  (especially  hemorrhagic  colitis)  and  hemolytic  uremic
yndrome  were  closely  associated  with  STEC  types  carrying
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Shiga  toxin-producing  Escherichia  coli  
the  eae  gene  for  intimin.10 Additionally,  enterohemolysin,
expressed  by  the  ehxA  gene,  liberates  hemoglobin  from  the
red  blood  cells  during  infection  and  has  been  linked  to  severe
disease.11
The  aim  of  the  present  study  was  to  identify  the  serotypes
and  virulence  genes  of  STEC  isolates  recovered  from  human
and  sheep  fecal  materials  to  ascertain  if  ovine  STEC  strains
possess  the  same  serotypes  and  virulence  proﬁles  as  STEC
strains  that  cause  human  infections.  Chromosomal  DNAs  of
O157:H7  isolates  were  analyzed  by  pulsed-ﬁeld  gel  elec-
trophoresis  (PFGE)  to  determine  the  isolates  potential  as
human  pathogen  and  the  genetic  relatedness  to  obtain  a
better  understanding  of  the  relevant  sources  of  zoonotic
O157:H7  isolates.  Susceptibility  of  the  isolates  to  eleven
commonly  used  antibiotics  was  also  investigated.
Materials and methods
Sampling
Stool  samples  were  collected  from  patients  with  diarrhea
from  Ouhud  Hospital  at  Al-Madinah  Al-Munawarah,  demo-
graphic  data  of  human  patients  were  depicted  in  Table  1.
Fecal  samples  were  collected  from  randomly  selected  sheep
at  the  central  sheep  market  in  Al-Madinah  Al-Munawarah
between  June  and  August  2015.  A  total  of  221  samples;
134  human  samples  and  87  sheep  samples,  were  collected
into  appropriate  capped  tubes.  Samples  were  transferred
on  ice  to  Taibah  University  microbiology  laboratory,  biology
department  for  immediate  processing.
Isolation  and  identiﬁcation  of  STEC
Isolation  of  E.  coli  O157:H7:  approximately  1  g  of  each  fecal
sample  was  mixed  in  9  ml  of  Trypticase  soya  broth  (TSB)  with
20  mg/L  novobiocine  and  incubated  for  6--8  h  at  41.5 ◦C  for
6  h  then  transferred  and  plated  onto  sorbitol  MacConkey  agar
(SMAC)  supplemented  with  1  mg/L  potassium  tellurite  and
incubated  for  18--24  h  at  37 ◦C.  A  pale  colony  each  (sorbitol
non-fermenters)  was  picked  as  presumptive  E.  coli  O157  per
sample  and  were  conﬁrmed  to  be  E.  coli  biochemically  by
the  indole,  methyl  red,  Voges-Proskauer,  and  citrate  testsPlease  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
(IMViC).12
Isolation  of  non-O157  STEC  strains:  fecal  sample  were
cultured  on  SMAC  agar  (Difco)  by  the  streak  plate  technique.
After  overnight  incubation  of  the  plates  at  37 ◦C,  colonies
D
s
l
c
Table  1  Basic  demographics  and  prevalence  of  Shigatoxin-produc
Characteristics  No.  of  patients  (%)  n  =  30  
Gender
Female  13  (43.3%)  
Male 17  (56.7%)  
Age (years)
0--4  13  (43.3%)  
5--19 7  (23.3%)  
20--63 10  (33.3%)   PRESS
3
ere  conﬁrmed  by  the  indole,  methyl  red,  Voges-Proskauer,
nd  citrate  tests  (IMViC).
omatic  and  ﬂagellar  serotyping
solates  were  grown  on  nutrient  agar  plates  at  37 ◦C
vernight,  then  the  cells  were  collected  and  suspended  in
.9%  sterile  normal  saline  (154  mEq/L  sodium  and  154  mEq/L
hloride,  pH  adjusted  to  7)  then  autoclaved  at  121 ◦C  for
5  min.  The  cells  were  concentrated  by  centrifugation  and
uspended  in  an  appropriate  volume  of  sterile  normal  saline.
etection  of  O-serogroup  was  performed  using  a  commer-
ially  available  O-serogrouping  Kit.13 The  Flagellar  phase
nversion  was  carried  out  using  the  standard  Craigie  tube
echnique  by  passage  through  semi-solid  agar  containing  the
ppropriate  ﬂagellar  antisera.14
ntimicrobial  susceptibility  testing
he  antimicrobial  susceptibility  phenotypes  of  Shiga  toxin-
roducing  E.  coli  (STEC)  strains  from  human  patients  and
heep  was  performed  following  the  standard  disc  diffusion
ethod  on  Muller-Hinton  agar  plates,  using  commercially
vailable  antimicrobial  susceptibility  discs  (Kirby-Bauer
N  DISC)  according  to  the  standards  and  interpretive
riteria  described  by  CLSI.15 The  following  antibiotics  were
sed  ampicillin  (10  /disk),  oxytetracyclin  (30  /disk),
entamycin  (30  /disk),  ciproﬂoxacin  (5  /disk),  cefo-
axime  (30  /disk),  streptomycin  (15  /disk),  noroﬂoxacin
30  /disk),  polymyxin  (300  /disk),  chloromphenicol
30  /disk),  Kanamycin  (30  /disk)  and  trimetoprime-
ulfamethoxazole  (23.75  /disk).  The  results  were  recorded
n  the  basis  of  the  zone-size  interpretative  chart  supplied
y  the  manufacturer.
emplate  DNA  preparation
NA  templates  for  PCR  were  obtained  from  overnight  E.  coli
ultures  that  were  harvested,  then  suspended  in  200  ml  of
terile  distilled  water,  and  boiled  for  15  min.16
etection  of  virulence  genesI.  Prevalence  and  molecular  characterization  of  Shiga
 sheep  in  Al-Madinah  Al-Munawarah.  Infectio.  2016.
etection  of  virulence  genes  was  performed  by  PCR.  Primer
equences  and  PCR  conditions  used  for  the  study  were
isted  in  Table  2.17 PCR  performed  in  the  Takara  thermal
ycler  (Bio-Rad,  USA).  PCR  products  were  separated  and
ing  Escherichia  coli  among  human  patients.
O157  (n  =  21)  Non-O157  (n  =  9)
7  (33.3%)  4  (44.4%)
14  (66.7%)  5  (55.6%)
10  (47.6%)  4  (44.4%)
3  (14.3%)  2  (22.2%)
8  (38.1%)  3  (33.3%)
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Table  2  PCR  primers  and  conditions  for  ampliﬁcation  of  virulence  genes.
Target  gene  Primer
designation
Primer  sequence  (5′--3′)  PCR  conditions* Length  (bp)
Stx1 (Shiga-toxin1)
KS7  CCCGGATCCATGAAAAAAACATTATTAATAGC  95 ◦C,  30  s;
52 ◦C,  30  s;
72 ◦C,  30  s
285
KS8 CCCGAATTCAGCTATTCTGAGTCAACG
Stx2 (Shiga-toxin2)
VT2e  AATACATTATGGGAAAGTAATA  95 ◦C,  30  s;
52 ◦C,  30  s;
72 ◦C,  30  s
348
VT2f TAAACTGCACTTCAGCAAAT
eae (intimin
genes)
SK1  CCCGAATTCGGCACAAGCATAAGC  95 ◦C,  30  s;
61 ◦C,  30  s;
72 ◦C,  30  s
863
SK2 CCCGGATCCGTCTCGCCAGTATTCG
ehxA
(EHEC-hemolysin)
HlyA1  GGTGCAGCAGAAAAAGTTGTAG  95 ◦C,  30  s;
61 ◦C,  30  s;
72 ◦C,  30  s
1550
HlyA4 TCTCGCCTGATAGTGTTTGGTA
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s* 34 cycles of ampliﬁcation and a ﬁnal extension step of 72◦C fo
isualized  by  gel  electrophoresis  in  1.5%  agarose  (Wako)  in
ris--acetate--EDTA  (TAE)  buffer  at  100  V,  where  a  100  or
00  bp  DNA  ladder  (one-step  ladder,  Wako)  was  included  in
ach  agarose  run,  accordingly  the  ampliﬁed  product.
ulsed  ﬁeld  gel  electrophoresis  (PFGE)
FGE  was  performed  according  to  CDC  (the  PulseNet  pro-
ocol  of  the  Centers  for  Disease  Control  and  Prevention).
he  agarose-embedded  bacterial  genomic  DNA  was  digested
ith  restriction  enzyme  XbaI  at  37 ◦C  for  4  h.  Electrophoresis
as  performed  on  1%  agarose  gel  with0.5  Tris--borate--EDTA
uffer.  The  electrophoretic  conditions  were  optimized  for
he  separation  of  the  24-  to  600-kB  XbaI-digested  macrore-
triction  fragments.  The  following  PFGE  parameters  were
pplied:  voltage  of  6  v/cm,  initial  switch  time  of  2.2  s,  ﬁnal
witch  time  of  54.2  s,  and  run  time  of  19  h.  Electrophoresis
as  conducted  by  using  a  CHEF-DRII  (Bio-Rad  Laboratories,
okyo,  Japan).  The  gel  was  stained  with  ethidium  bromide
nd  imaged  with  the  Gel  Doc  2000  and  Multi-Analyst  pro-
ram  (Bio-Rad).  Dendrograms  were  created  with  a  Molecular
nalyst  (Bio-Rad)  using  the  Dice  coefﬁcient,  unweighted  pair
roup  method  with  arithmetic  means  (UPGMA)  and  a  position
olerance  of  1.3%.
esults
higa  toxin-producing  E.  coli  O157  strains
 total  of  28  isolates  (17  human  isolates  and  11  sheep
solates)  showed  typical  colony  phenotype  (sorbitol  nega-Please  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
ive),  had  IMViC  reactions  characteristic  of  E.  coli  (+  +  −
),  agglutinated  with  O157  and  H7  antisera  and  possessed
pecies-speciﬁc  gene  (uidA).18 Four  O157:HNM  isolates  were
ecovered  from  humans  (Table  3).
a
2
a
cin were performed for all of the PCR protocols described.
higatoxin-producing  E.  coli  non-O157  strains
 variety  of  non-O157  Shiga  toxin-producing  E.  coli  reported
n  the  present  study  belong  to  4  (O)  serogroups  and  6  (O:
)  serotypes  (Table  4).  The  most  prevalent  serotype  among
uman  patients  was  O26:H11  (5/48;  10.4%)  and  O26:  HNM
2/48;  4.2%).  Two  isolates  (2/48;  4.2%)  belong  to  serotype
128:  H2;  one  isolated  from  human  and  the  other  from
heep.  Serotype  O48:  HNM  was  reported  only  among  sheep
solates  (2/48;  4.2%).  Single  strain  (1/48;  2.1%)  of  serotype
111:  HNM  was  recovered  from  human  patient,  while  four
4/48;  8.4%)  untypable  strains  were  isolated  from  sheep.
ntibiotics  susceptibility  of  Shiga-toxin  E.  coli
solates
he  phenotypic  testing  of  antibiotics  susceptibility  of  the
8  Shiga  toxin-producing  E.  coli  (STEC)  isolates,  showed
igh  prevalence  of  multi-resistance  to  various  antimicrobial
gents.  Human  STEC  O157:H7  strains  exhibited  resistance
o  oxytetracyclin,  trimethoprime--sulphamethoxazole,
anamycin,  streptomycin,  chloramphenicol,  ampicillin,
oroﬂoxacin  and  gentamycin  (76.5%,  72.1%,  56.1%,  49.2%,
5.1%,  24.1%,  17.2%  and  12.3%  respectively),  while  sheep
trains  of  O157:H7  showed  the  same  resistance  pattern
s  human  strains  except  for  the  resistance  to  strep-
omycin,  chloramphenicol  and  ampicillin  were  (47.1%,
3.1%  and  25.3%  respectively)  (Table  3).  STEC  non-O157
trains  indicated  slightly  lower  resistance  to  oxytetra-
yclin,  trimethoprime--sulphamethoxazole,  kanamycin,
treptomycin,  chloramphenicol,  ampicillin,  noroﬂoxacinI.  Prevalence  and  molecular  characterization  of  Shiga
 sheep  in  Al-Madinah  Al-Munawarah.  Infectio.  2016.
nd  gentamycin  (74.3%,  67.6%,  52.7%,  45.1%,  31.8%,
3.7%,15.7%  and  10.3%  respectively)  (Table  4).  However,
ll  isolates  showed  100%  susceptibility  to  polymyxin  B,
iproﬂoxacin  and  cefotaxime.
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Table  3  Serotypes,  virulence  factors  and  antibiotics  resistance  pattern  of  O157  Shigatoxin-producing  Escherichia  coli.
Source  No.  of  isolates  Percentage*  Serotype  Presence  of  virulence
genes  (no.  of  isolates)
Antibiotics  resistance
pattern  (%  of  strains)
Human  17  35.4%  O157:H7  Stx1,  Stx2,  eaeA,
ehxA  (9)
Stx1, stx2,  eaeA  (1)
Stx1,  Stx2  (1)
Stx1,  Stx2,  ehxA  (3)
Stx2, eaeA  (3)
AMP  (24.1%),
OTC  (76.5%),  K  (56.1%),
STX  (72.1%),  S  (49.2%),
C  (35.1%),  GM  (12.3%),
NOR  (17.2%)
Sheep 11  22.9%  O157:H7  Stx1,  Stx2,  eaeA,
ehxA  (4)
Stx1, Stx2,  eaeA  (3)
Stx1, Stx  2,  ehxA  (1)
Stx2, eaeA,  ehxA  (2)
Stx2, eaeA  (1)
AMP  (25.3%),
OTC  (76.5%),  K  (56.1%),
STX  (72.1%),  S  (47.1%),
C  (33.1%),  GM  (12.3%),
NOR  (17.2%)
Human 4  8.3%  O157:HNM  Stx2,  eaeA  (4)  AMP  (24.1%),
OTC  (74.3%),  K  (54.1%),
STX  (72.1%),  S  (49.2%),
C  (35.1%),  GM  (12.3%),
NOR  (17.2%)
Table  4  Serotypes,  virulence  factors  and  antibiotics  resistance  pattern  of  non-O157  Shigatoxin-producing  Escherichia  coli.
Source  No.  of
isolates
Percentage* Serotype  Presence  of  virulence
genes  (no.  of  isolates)
Antibiotics  resistance
pattern  (%  of  strains)
Human  5  10.4%  O26:H11  Stx1,  eaeA  (5)
AMP  (23.7%),  OTC  (74.3%),
K (52.7%),  STX  (67.6%),
S  (45.1%),  C  (31.8%),
GM  (10.3%),  NOR  (15.7%)
Human 2  4.2%  O26:HNM  Stx1,  eaeA  (2)
Human 1  2.1%  O128:H2  Stx1,  eaeA
Sheep 1  2.1%  O128:H2  Stx1,  eaeA
Sheep 2  4.2%  O48:HNM  Stx1,  Stx2  (2)
Human 1  2.1%  O111:HNM  Stx1,  eaeA
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* The percentage was calculated as the proportion of the numbe
Virulence  genes  distribution  among  different  STECs
serotypes
Forty  eight  conﬁrmed  E.  coli  isolates  were  analyzed  by
PCR  for  the  presence  of  stx1,  stx2,  eaeA, ehxA; the  char-
acteristic  virulence  genes  of  STECs.  The  distribution  of
the  virulence  genes  showed  a  variety  of  virulence  proﬁles
among  STEC  O157  (Table  3)  and  non-O157  isolates  (Table  4).
The  predominant  genotype  among  the  tested  E.  coli
O157:H7  isolates  was  stx1,  stx2,  ehxA  and  eae, accounting
for  13  of  the  28  (46.4%).  Of  the  remaining  isolates,  four
(14.3%)  were  stx2 and  eaeA; four  (14.3%)  were  stx1, stx2
and  ehxA; four  (14.3%)  were  stx1,  stx2 and  eaeA; two
(7.1%)  were  stx1,  eaeA, ehxA  and  one  (3.6%)  was  stx1,  stx2
and.  Four  human  O157:HNM  isolates  possessed  stx2 and
eaeA  genotype.  Among  the  16  non-O157  STEC  isolates,  ten
(62.5%)  were  stx1 and  eaeA; four  (25%)  were  stx2 and  eaeA
and  two  (12.5%%)  were  stx1 and  stx2 (Table  4).Please  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
PFGE  proﬁles  of  E.  coli  O157:H7  isolates
Thirteen  different  PFGE  patterns  named  A  through  M,  were
found  among  the  28  E.  coli  O157:H7  isolates  (15  human
r
a
s
lStx2,  eaeA  (4)
isolates divided by the number of total isolates.
solates,  13  sheep  isolates).  As  indicated  in  Fig.  1, the  pre-
ominant  PFGE  pattern  seen  from  the  human  and  ovine
.  coli  O157:H7  isolates  was  pattern  H  (25%);  including  both
uman  and  sheep  isolates  with  more  than  80%  similarity,
ollowed  by  pattern  C  (14.3%)  and  pattern  L  (10.7%).  The
bserved  PFGE  pattern  was  signiﬁcantly  associated  with  the
enotype.  Isolates  with  PFGE  patterns  H,  C,  E,  and  M  all  had
he  stx1, stx2,  ehxA  and  eaeA  genotype.  However,  E.  coli
157:H7  isolates  with  the  other  PFGE  patterns  possessed  a
ariety  of  genotypes,  such  as  stx1,  stx2 and  eaeA  (A  and  I);
tx1,  stx2 and  ehxA  (B,  D,  F and  G);  stx1 and  stx2 (J)  or  stx2
nd  eaeA  (K  and  L)
iscussion
he  present  study  investigated  Shiga  toxin-producing  E.  coli
STEC)  in  human  and  sheep  fecal  materials  in  Al-Madinah
l-Munawarah,  Saudi  Arabia;  where  people  depend  mainly
n  sheep  meat.  To  our  knowledge  this  study  is  the  ﬁrst  toI.  Prevalence  and  molecular  characterization  of  Shiga
 sheep  in  Al-Madinah  Al-Munawarah.  Infectio.  2016.
eport  the  presence  of  O157  and  non-O157  STEC  in  human
nd  sheep  fecal  materials  in  Saudi  Arabia.  A  total  of  221  fecal
amples  (134  human  and  87  sheep)  were  collected  and  ana-
yzed  for  the  presence  of  STEC  strains.  A  total  of  48  STEC
ARTICLE IN PRESS+ModelINFECT-116; No. of Pages 8
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Figure  1  Dendogram  of  PFGE  patterns  calculated  with  using  UPGMA  cluster  analysis,  Dice  similarity  coefﬁcient,  and  1%  band
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(atching tolerance  for  STEC  O157:H7  strains.  Stx1,  Shiga-toxin
solates  conﬁrmed  biochemically,  serologically  and  by  PCR
argeting  the  characteristic  virulence  genes  stx1,  stx2,  eaeA
nd  ehxA. The  highest  number  of  reported  STECs  among
uman  patients  was  reported  in  the  youngest  age  category
46.7%)  and  in  males  (63.3%).  Higher  prevalence  of  O157
han  non-O157  Shiga  toxin  producing  E.  coli  was  reported
mong  human  and  sheep  samples  especially  E.  coli  O157:H7
erotype.  The  high  frequency  of  E.  coli  O157:H7  serotype
an  be  explained  by  the  fact  that  the  samples  were  col-
ected  during  summer  when  they  are  known  to  increase.19
heep  are  a  natural  reservoir  for  E.  coli  O157:H7,  in  addition,
heep  have  also  been  cited  as  reservoirs  for  a  diverse  num-
er  of  non-O157  Shiga  toxin-producing  E.  coli  serogroups,
hich  have  been  implicated  in  human  disease.20,21 A  good
nderstanding  of  the  primary  animal  reservoirs  would  be
rucial  for  the  development  of  control  measures  of  any  risk
actors  that  could  lead  to  human  infections  with  zoonotic
TEC,  given  that  sheep  are  considered  relevant  reservoirs
f  zoonotic  STEC.5,22 Lack  of  hygienic  practices  could  poten-
ially  contribute  to  the  transmission  of  pathogens  from
heep  meat  to  human.  Previous  studies  had  suggested  that
TEC  prevalence  in  feces  was  correlated  with  the  pathogen’s
revalence  on  carcasses.23--25
Diarrhea  caused  by  E.  coli  requires  antimicrobial  ther-
py;  however,  antibiotic-resistant  strains  cause  longer  and
ore  severe  illnesses  than  their  antibiotic-susceptible
ounterparts.  Several  studies  have  shown  that  antibiotic
esistance  in  E.  coli  has  increased  over  time.26,27 Inves-Please  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
igation  of  antimicrobial  resistance  revealed  a  very  high
evel  of  multiple  antimicrobial  resistances  among  the  iso-
ates  and  the  most  common  resistance  was  to  tetracycline
w
b
ox2,  Shiga-toxin2;  eaeA,  intimin  gene;  ehxA,  EHEChaemolysin.
hich  was  often  used  as  a  ﬁrst-line  antimicrobial  and
rowth  promoter  in  food  animals  and  its  widespread
se  has  contributed  to  high  rates  of  resistance.28 The
requency  of  tetracycline  resistance  among  the  E.  coli
solates  was  76.5--74.3%  which  is  within  the  range  of
alues  described  in  previous  reports  (68--93%).29,30 STECs
solates  of  the  present  study  also  showed  high  resistance
o  trimethoprime--sulphaethoxazole,  kanamycine,  strep-
omycin,  chloromphenicol  and  Ampicillin.  Knowledge  of
ecent  regional  patterns  of  antimicrobial  resistance  is  crit-
cal  to  therapeutic  decision-making.  To  our  knowledge
his  is  the  ﬁrst  report  on  STEC  isolates  from  human  and
heep  in  Saudi  Arabia.  Therefore,  no  previous  studies
ere  reported  to  compare  our  results,  but  we  can  com-
are  the  results  with  other  countries.  In  Iraq  a  study
n  children  revealed  resistance  of  O157:H7  strains  to
rythromycin,  polymyxin  B  and  vancomycin  and  suscepti-
ility  to  cephalexin,  ciproﬂoxacin,  gentamicin  and  nalidixic
cid.31 A  study  on  STEC  isolated  from  ruminants,  reported
 high  resistance  (>65%)  to  tetracycline,  streptomycin,
rythromycin,  and  sulfamethoxazole.  Moreover,  a  high
esistance  (30%)  to  ampicillin,  chloramphenicol,  trimetho-
rim,  and  trimethoprim-sulfamethoxazole  and  susceptibility
>90%)  to  gentamicin  and  colistin  was  reported.32 O157:H7
uman  strains  recorded  a  resistance  to  tetracycline,  sul-
hamethoxazole  and  erythromycin.33 A  high  resistance  of
TEC  strains  to  penicillin  (100%),  followed  by  tetracycline
86.88%),  gentamicin  (62.29%)  and  streptomycin  (54.91%)I.  Prevalence  and  molecular  characterization  of  Shiga
 sheep  in  Al-Madinah  Al-Munawarah.  Infectio.  2016.
as  also  reported.27 In  this  regard,  the  use  of  antimicro-
ials  in  food  producing  animals  resulting  in  the  transmission
f  resistant  bacteria  by  the  food  vehicle.
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STEC  human  and  sheep  isolates  possessed  various  com-
binations  of  the  virulence-associated  genes.  The  most
common  virulence  genotype  among  STEC  O157  strains  in
which  40.6%  of  the  isolates  are  stx1,  stx2,  eaeA, ehxA.  Many
reports  attempted  to  correlate  the  presence  of  speciﬁc  rec-
ognized  virulence  factors  with  disease  or  severity  of  disease
and  concluded  that  no  single  factor  is  responsible  for  the
virulence  of  STEC.34,35 Previous  studies  have  shown  a  cer-
tain  degree  of  homogeneity  for  the  presence  of  virulence
factors  within  STEC  serotypes.36 The  present  study  showed
that  stx1 was  signiﬁcantly  more  frequent  in  isolates  from
O157  and  non-O157  serotypes,  followed  by  stx2 and  none  of
the  strains  lack  either  stx1 or  stx2.  ehxA  was  observed  to  be
frequent  between  isolates  from  O157  serotypes,  but  com-
pletely  absent  in  non-O157  serotypes.  eaeA  also  seems  to
be  restricted  to  O157  serotypes  except  serotype  O26:H11.
Our  results  are  in  agreement  with  previous  studies  which
reported  that  ehxA,37 eae,38 and  stx239 are  found  more  fre-
quently  in  O157  isolates  from  patients  with  severe  disease
than  in  other  STEC  populations.  Interestingly,  STEC  isolates
from  sheep  showed  the  same  pattern  of  distribution  of  the
virulence  genes  among  different  serotypes  in  parallel  with
human  isolates.
PFGE  remains  an  effective  tool  for  detecting  varia-
tion  between  closely  related  strains.  Analysis  of  E.  coli
populations  by  use  of  PFGE  has  shown  that  serotype  is
a  good  marker  for  the  genetic  background  of  STEC  in
terms  of  unknown  virulence  factors  involved  in  the  patho-
genesis  of  STEC-associated  diseases.1 This  approach  was
followed  in  the  present  study  to  describe  genetic  links
between  virulence  and  serotype.  PFGE  and  genotyping  are
complementary  methods  as  PFGE  primarily  detects  inser-
tion/deletion  variation  within  genomic  regions  speciﬁc  to
STEC  O157.40 Thus,  genotyping  combined  with  PFGE  could
be  very  useful  in  assessing  strain  diversity  and  evolutionary
relatedness  between  epidemiologically  unrelated  strains.
On  the  basis  of  combined  genotype  and  PFGE  proﬁle,  we
are  able  to  distinguish  human  and  sheep  O157:H7  isolates
obtained  in  the  present  study.  The  isolates  were  revealed
in  two  main  clusters,  each  cluster  included  human  and
sheep  isolates  in  a  high  percentage  of  homology.  The  most
prevalent  PFGE  pattern  among  the  isolates  was  (H),  which
including  5  human  isolates  and  2  sheep  isolates  with  over
80%  homology  percentage  indicating  that  the  strains  were
almost  the  same.  Together  with  almost  equal  distributions  of
virulence  genes  found  among  ovine  and  human  isolates  indi-
cate  localized  transmission  between  sheep  and  humans.  The
observed  clustering  of  isolates  was  explained  by  their  geno-
types.  Together  with  the  signiﬁcant  associations  between
human  and  sheep  isolates,  provide  further  evidence  of  an
animal/environmental-associated  pathway  of  sporadic  STEC
infection.
The  present  study  supports  the  concept  that  sheep  are
a  natural  reservoir  for  potentially  virulent  E.  coli  O157:H7
and  non-O157  STEC  strains.  In  addition  sheep  strains  of
E.  coli  O157:H7  are  closely  related  to  human  isolates.  Our
results  cannot  be  used  to  establish  a  direct  cause-and-
effect  relationship  between  pathogen  prevalence  in  sheepPlease  cite  this  article  in  press  as:  Sharaf  EF,  Shabana  I
toxin-producing  Escherichia  coli  isolates  from  human  and
http://dx.doi.org/10.1016/j.infect.2016.05.001
fecal  materials  and  human  pathogenicity.  Further  studies
are  needed  to  determine  the  relevance  of  these  implica-
tions. PRESS
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